Diagnostic Efficacy of 18F-FAPI-74 PET/CT in Patients with Pancreatic Cancer

Brief summary (registry, in English)

To assess the accuracy of 18F-FAPI-74 PET/CT in detection of local lymph node metastasis in patient level in patients with primary pancreatic cancer.

What you commit to

• Study type: Interventional · Phase 2
• Planned participants: 100
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

AI-kivonat: who the study is looking for

Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with pancreatic cancer, or suspected pancreatic cancer, to test how well 18F-FAPI-74 PET/CT scans find cancer spread to nearby lymph nodes.

Age

18-85 years

Sex

Men and women

Disease stage

Primary or recurrent pancreatic cancer, or suspected primary or recurrent pancreatic cancer

Main reasons for not taking part

• Vulnerable people named in Finnish clinical study law (disabled, children, pregnant or breast-feeding women, prisoners)
• Cannot understand the purpose of the study
• Medical conditions that rule out whole-body PET/CT imaging

Read by machine on 9 Nov 2026.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

Are you the coordinator? Confirm the details